In fact, the regulatory effects of miR-19a may provide a missing link to our understanding of immune regulation and the progesssion of cancer and anti-viral immunity, that in the future may be harnessed to control inflammatory disorders associated with dysregulated JAK-STAT signalling. The gene discussed is SOAT1; the disease is cancer.